Literature DB >> 32329843

Circular RNA circCNOT6L regulates cell development through modulating miR-384/FN1 axis in esophageal squamous cell carcinoma.

Y Zhang1, Q Tang, X-M Huang, D-Z Liao.   

Abstract

OBJECTIVE: In recent years, circular RNAs (circRNAs) and microRNAs (miRNAs) have been shown to be related to the development of esophageal squamous cell carcinoma (ESCC). However, their functional mechanisms remain to be investigated. Herein, we focus our research on the functions and mechanisms of circCNOT6L and miR-384 in ESCC.
MATERIALS AND METHODS: The levels of circCNOT6L, miR-384, and fibronectin 1 (FN1) were determined using quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). RNase R was used to investigate circCNOT6L stabilization. Cell proliferation and apoptosis were assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and flow cytometry, respectively. Western blot assay was employed to analyze the protein levels of FN1, proliferation-related genes, and iron metabolism-related genes. In addition, the interaction between miR-384 and circCNOT6L or FN1 was predicted by starBase3.0 and confirmed by the Dual-Luciferase reporter assay. Mouse xenograft was carried out to measure the effect of circCNOT6L on tumor growth in vivo.
RESULTS: CircCNOT6L and FN1 levels were upregulated, and miR-384 level was downregulated in ESCC tissues/cells. CircCNOT6L knockdown attenuated ESCC cell proliferation and iron metabolism disorder, as well as accelerated apoptosis. Notably, circCNOT6L targeted miR-384, and miR-384 targeted FN1. MiR-384 depletion and FN1 upregulation weakened the effects of circCNOT6L knockdown and miR-384 overexpression on ESCC cell progression, respectively. Besides, circCNOT6L knockdown inhibited tumor growth in vivo.
CONCLUSIONS: Our results demonstrated that circCNOT6L positively regulated the development of ESCC cells via modulating miR-384/FN1 axis. Our findings provided a theoretical basis for the therapy of ESCC patients.

Entities:  

Year:  2020        PMID: 32329843     DOI: 10.26355/eurrev_202004_20830

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

Review 1.  Regulation of ferroptosis by noncoding RNAs: a novel promise treatment in esophageal squamous cell carcinoma.

Authors:  Guanen Qiao; Wenjuan Zhang; Kui Dong
Journal:  Mol Cell Biochem       Date:  2022-04-21       Impact factor: 3.842

Review 2.  Current advances and future perspectives on the functional roles and clinical implications of circular RNAs in esophageal squamous cell carcinoma: more influential than expected.

Authors:  Chenxi Ju; Jing He; Chang Wang; Jinxiu Sheng; Jinlin Jia; Dan Du; Hongle Li; Mingxia Zhou; Fucheng He
Journal:  Biomark Res       Date:  2022-06-07

3.  Circ-ATIC Serves as a Sponge of miR-326 to Accelerate Esophageal Squamous Cell Carcinoma Progression by Targeting ID1.

Authors:  Bing Zhang; Weiwei Chu; Zhe Li; Yaxiao Zhang; Qiang Zhen; Baolei Lv; Jiabao Liu; Caiping Lu; Xiaojian Zhao
Journal:  Biochem Genet       Date:  2022-01-22       Impact factor: 2.220

Review 4.  Biological and clinical implications of metastasis-associated circular RNAs in oesophageal squamous cell carcinoma.

Authors:  Xin Fang; Sachin Mulmi Shrestha; Li-Hua Ren; Rui-Hua Shi
Journal:  FEBS Open Bio       Date:  2021-10-16       Impact factor: 2.693

Review 5.  circRNA: A New Biomarker and Therapeutic Target for Esophageal Cancer.

Authors:  Katsutoshi Shoda; Yuki Kuwano; Daisuke Ichikawa; Kiyoshi Masuda
Journal:  Biomedicines       Date:  2022-07-08

6.  PTPRM methylation induced by FN1 promotes the development of glioblastoma by activating STAT3 signalling.

Authors:  Jian Song; Di Zhao; Guozhu Sun; Jiankai Yang; Zhongqiang Lv; Baohua Jiao
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.